WT WisdomTree, Inc.

NYSE www.wisdomtree.com


$ 11.78 $ 0.09 (0.77 %)    

Monday, 10-Nov-2025 15:50:08 EST
QQQ $ 623.70 $ 4.91 (0.79 %)
DIA $ 473.62 $ 1.77 (0.38 %)
SPY $ 681.60 $ 4.42 (0.65 %)
TLT $ 89.47 $ -0.01 (-0.01 %)
GLD $ 378.25 $ 2.31 (0.61 %)
$ 11.58
$ 11.66
$ 11.77 x 220
$ 11.78 x 845
$ 11.53 - $ 11.82
$ 7.43 - $ 14.96
2,777,992
na
nm
$ 0.96
nm
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 05-09-2025 03-31-2025 10-Q
4 02-26-2025 01-01-1970 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-02-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 02-23-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-04-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 02-28-2023 12-31-2022 10-K
13 11-04-2022 09-30-2022 10-Q
14 08-05-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 02-25-2022 12-31-2021 10-K
17 11-05-2021 09-30-2021 10-Q
18 08-06-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 02-19-2021 12-31-2020 10-K
21 11-06-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-08-2020 03-31-2020 10-Q
24 02-28-2020 12-31-2019 10-K
25 11-01-2019 09-30-2019 10-Q
26 07-31-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 03-01-2019 12-31-2018 10-K
29 11-07-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-10-2018 03-31-2018 10-Q
32 03-01-2018 12-31-2017 10-K
33 11-08-2017 09-30-2017 10-Q
34 08-08-2017 06-30-2017 10-Q
35 05-08-2017 03-31-2017 10-Q
36 03-01-2017 12-31-2016 10-K
37 11-09-2016 09-30-2016 10-Q
38 08-09-2016 06-30-2016 10-Q
39 05-09-2016 03-31-2016 10-Q
40 02-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 goldman-sachs-maintains-neutral-on-wisdomtree-raises-price-target-to-145

Goldman Sachs analyst Alexander Blostein maintains WisdomTree (NYSE:WT) with a Neutral and raises the price target from $12....

 morgan-stanley-maintains-equal-weight-on-wisdomtree-raises-price-target-to-135

Morgan Stanley analyst Michael Cyprys maintains WisdomTree (NYSE:WT) with a Equal-Weight and raises the price target from $1...

 pe-ratio-insights-for-wisdomtree
P/E Ratio Insights for WisdomTree
08/27/2025 22:00:26

 morgan-stanley-maintains-equal-weight-on-wisdomtree-raises-price-target-to-125

Morgan Stanley analyst Michael Cyprys maintains WisdomTree (NYSE:WT) with a Equal-Weight and raises the price target from $1...

 wisdomtree-announces-plans-to-offer-400m-in-convertible-senior-notes-due-2030-through-a-private-offering

WisdomTree, Inc. (NYSE:WT) ("WisdomTree"), a global financial innovator, today announced its intention to offer, subjec...

 wisdomtree-q2-adj-eps-018-beats-017-estimate-sales-112621m-beat-111370m-estimate

WisdomTree (NYSE:WT) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.17 by 2.86 ...

 wisdomtree-announces-acquisition-of-ceres-partners-terms-not-disclosed

Strategic acquisition jumpstarts WisdomTree's entry into the private asset markets, with a focus on a high-growth $3.5 tril...

 oppenheimer-maintains-outperform-on-wisdomtree-raises-price-target-to-15

Oppenheimer analyst Chris Kotowski maintains WisdomTree (NYSE:WT) with a Outperform and raises the price target from $12 to ...

 wisdomtrees-new-geoa-etf-bets-on-geopolitics-tech-shifts-and-global-power-plays

WisdomTree's new GeoAlpha Opportunities Fund targets global companies poised to gain from shifting geopolitical, economic, ...

 morgan-stanley-maintains-equal-weight-on-wisdomtree-raises-price-target-to-11

Morgan Stanley analyst Michael Cyprys maintains WisdomTree (NYSE:WT) with a Equal-Weight and raises the price target from $9...

 goldman-sachs-upgrades-wisdomtree-to-neutral-raises-price-target-to-119

Goldman Sachs analyst Alexander Blostein upgrades WisdomTree (NYSE:WT) from Sell to Neutral and raises the price target from...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION